Foresite Capital Management V, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Foresite Capital Management V, LLC held in its portfolio 7 assets valued at $164,402,957 (i.e. $164.40M).

The most valuable assets in the portfolio included: ALUMIS INC. ($56.41M), CG Oncology, Inc. ($41.69M), and Disc Medicine, Inc. ($23.75M).

The chart below shows the top 7 valuable assets, and the table below shows the top 7 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Foresite Capital Management V, LLC Portfolio

ALUMIS INC.

CG Oncology, Inc.

Disc Medicine, Inc.

Natera, Inc.

Lyell Immunopharma, Inc.

Hims & Hers Health, Inc.

Maze Therapeutics, Inc.

Foresite Capital Management V, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ALUMIS INC.	5779348	56406436	COM
CG Oncology, Inc.	1004050	41688156	COM
Disc Medicine, Inc.	299069	23749069	COM
Natera, Inc.	67356	15430586	COM
Lyell Immunopharma, Inc.	477078	14684461	COM
Hims & Hers Health, Inc.	273151	8869213	COM CL A
Maze Therapeutics, Inc.	86291	3575036	COM